This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Epo-Med Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Hiroshi Ochi: Innovator in Peptide Technology
Introduction
Hiroshi Ochi is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of peptide technology, particularly with his innovative work on anti-erythropoietin receptor peptides. His research has the potential to impact various medical applications.
Latest Patents
Hiroshi Ochi holds a patent for an anti-EpoR peptide. The patent describes a peptide with a specific structure that includes various amino acids and modifications. This invention aims to provide a novel approach to targeting erythropoietin receptors, which could have implications in treating certain medical conditions.
Career Highlights
Ochi is associated with Epo-Med Inc., where he continues to advance his research in peptide technology. His work has garnered attention in the scientific community, showcasing his dedication to innovation and development in this specialized field.
Collaborations
Hiroshi Ochi collaborates with esteemed colleagues such as Hiroyuki Kouji and Yoshiko Yasuda. These partnerships enhance the research environment and contribute to the advancement of their collective work in peptide technology.
Conclusion
Hiroshi Ochi's contributions to peptide technology, particularly through his patent on anti-erythropoietin receptor peptides, highlight his role as an innovator in the field. His ongoing work at Epo-Med Inc. and collaborations with fellow researchers further emphasize his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile